Promoting pyroptosis—an inflammatory form of programmed cell death—has become a promising treatment strategy for cancer. In ...

MicroRNA-33a and microRNA-33b are encoded within the mammalian SREBF1 and SRBF2 genes, respectively, and both SREBF1 and ...

Researchers identified a combination of two existing cancer drugs, letrozole and irinotecan, that reversed Alzheimer’s ...

A groundbreaking study led by researchers at the Masonic Medical Research Institute (MMRI) has identified a promising ...

Gasdermin C activation boosts type II immunity against helminths, and NSAIDs may someday offer a novel, repurposed treatment ...

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop diabetes after immunotherapy.

Researchers at Shanghai Jiao Tong University have produced fertile adult mice from embryos constructed entirely with male genetic material. Mice carrying only paternal DNA developed into fertile ...

I don’t think it’s a slam dunk.” Johnson said her enthusiasm about SC PD-1/PD-L1 inhibitors is tempered after speaking with the pharmacist at her practice, SCRI Oncology Partners.

By combining two antioxidant enzyme inhibitors, they have converted cancer cells in mice into healthy nerve cells.

Enlicitide decanoate is an investigational oral proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor.